Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

The U.S. generic drug supply is at a critical crossroad. With over 60% of generics made abroad, we face a fragile supply chain. This whitepaper analyzes how immediate tariffs to boost domestic manufacturing risk raising patient costs and disrupting access, and outlines the strategic, phased approach needed to secure our drug supply for the long term.

This content was originally published by DeepIntent.  Healthcare marketing is undergoing a transformation, with data-driven insights now serving as the foundation for how brands connect with consumers and providers. That’s why DeepIntent is excited to spotlight PurpleLab®, a data partner that’s helping pharmaceutical brands and agencies connect with their audiences in more effective and meaningful…

Collaboration with health data and analytics company enhances pharmaceutical ad campaign targeting and measurement VDX.tv Partners with PurpleLab Collaboration with health data and analytics company enhances pharmaceutical ad campaign targeting and measurement VDX.tv, a global leader in digital advertising solutions, today announced a strategic partnership with PurpleLab®, a leading healthcare analytics company powering evidence-based decisions…

As the healthcare industry continues to face data challenges, PurpleLab® is making significant investments in its data and infrastructure to reinforce its position as a trusted leader in real-world data (RWD). We’ve recently secured several new data sources that will dramatically improve the comprehensiveness and composition of our data.(RWD) and real-world evidence (RWE) earlier in the product lifecycle to inform decision-making.

PurpleLab®, a leading health data and analytics company, announced a strategic partnership with Innovare, a pioneer in hospital-based digital media solutions. Together, the companies are transforming how pharmaceutical brands engage physicians by combining Innovare’s network of 300+ hospitals with PurpleLab’s claims-derived healthcare provider (HCP) affiliation data, which includes over three million opted-in HCPs as well…

Although randomized controlled trials remain a cornerstone of evidence generation, pharmaceutical and biotech companies are increasingly recognizing the necessity of leveraging real-world data
(RWD) and real-world evidence (RWE) earlier in the product lifecycle to inform decision-making.

The healthcare analytics company partnered with Experian, DeepIntent, InsightsRx, and Comscore to deliver scale, precision, privacy-conscious targeting, and real-time measurement for pharmaceutical advertisers. PurpleLab®, the healthcare analytics company powering evidence-based decisions across life sciences, has announced a series of major partnerships with Experian, DeepIntent, InsightsRx, and Comscore. Together, these collaborations allow advertisers to use data…

Partnership introduces smarter, real-time HCP and DTC optimization leveraging PurpleLab®’s data and InsightsRx’s proprietary algorithmic intelligence. InsightsRx, a healthcare media company on a mission to transform real-world data into smarter, outcome-driven marketing, teams up with PurpleLab, a healthcare analytics company on a mission to make healthcare speak a single unified language to drive better outcomes….

Pharmaceutical brands and media platforms, including connected TV (CTV), can activate HIPAA-compliant audiences built on real-world clinical and claims data through a new collaboration between PurpleLab® and Experian. Targeting de-identified audiences is essential for engaging the right patients at pivotal moments in their health journey—maximizing ROI while safeguarding privacy and improving outcomes. Overall, prescription drugmakers…